Publication
MP72-15 THE INTERVAL BETWEEN DIAGNOSIS AND RADICAL CYSTECTOMY DOES NOT IMPACT THE OUTCOMES OF PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY
Evanguelos Xylinas, Kamran Zargar-Shoshtari, Jay Shah, Homayoun Zargar, Adrian Fairey, Laura Mertens, Maria Mir, Jorge Garcia, Andrew Stephenson, Laura-Maria Krabbe, Michael Cookson, Yair Lotan, Niels-Erik Jacobsen, Nilai Gandhi, Joshua Griffin, Jeffrey Montgomery, Nikhil Vasdev, Evan Yu, Nicholas Campain, Wassim Kassouf, Marc Dall'Era, Jo-An Seah, Cesar Ercole, Simon Horenblas, Srikala Sridhar, Jonathan McGrath, Jonathan Aning, Jonathan Wright, Andrew Thorpe, Todd Morgan, Jeff Holzbeierlein, Trinity Bivalacqua, Scott North, Daniel Barocas, Siamak Daneshmand, Bass Van Rhijn, Philippe Spiess, Colin Dinney, Peter Black, Shahrokh Shariat
The Journal of Urology, April 2015, Wolters Kluwer Health
DOI: 10.1016/j.juro.2015.02.2649